Multicentre European study comparing selection techniques for the isolation of CD34+ cells

Bone Marrow Transplantation

Volumn 23, Issue 11, 1999, Pages 1191-1196

  De Wynter, E A ^a   Ryder, D ^b   Lanza, F ^c   Nadali, G ^d   Johnsen, H ^e   Denning Kendall, P ^f   Thing Mortensen, B ^g   Silvestri, F ^h   Testa, N G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c S ANNA HOSPITAL   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f SOUTHMEAD HOSPITAL   (United Kingdom)

^g ROSKILDE UNIVERSITY   (Denmark)

^h UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Bone marrow; CD34+ cells; Colony forming cells; Peripheral blood progenitor cells; Positive selection; Umbilical cord blood

Indexed keywords

CD34 ANTIGEN;

ARTICLE; CELL ISOLATION; CELL SELECTION; COLONY FORMING CELL; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; MAGNETIC FIELD; PRIORITY JOURNAL;

EID: 0032972168     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701789     Document Type: Article

References (38)

1. Gluckman E, Broxmeyer H, Auerbach A. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA identical sibling. New Engl J Med 1989; 321: 1174-1178.
2. Wagner JE. Umbilical cord blood transplantation: overview of the clinical experience. Blood Cells 1994; 20: 227-234.
3. Wagner J, Kernan N, Steinbuch M. Allogeneic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214-219.
4. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
5. Shpall E, Jones R, Bearman S et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
6. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
7. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
8. + cell enumeration. J Hematother 1998; 7: 105-109.
9. + progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma and erythropoietin. Blood 1993; 81: 2579-2584.
10. + cells into the myeloid lineage. Blood 1992; 89: 1405-1412.
11. Emerson GE. Ex vivo expansion of hematopoietic precursor, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996; 87: 3082-3088.
12. Denning-Kendall P, Nicol A, Horsley H et al. Is in vitro expansion of human cord blood cells clinically relevant? Bone Marrow Transplant 1998; 21: 225-232.
13. Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self-renewal of human hematopoietic stem cells from cord blood. Blood 1997; 89: 2644-2653.
14. Zandstra PW, Conneally E, Petzer AL et al. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 1997; 94: 4698-4703.
15. + progenitor cells cultured in serum-depleted medium. Stem Cells 1997; 15: 18-32.
16. Bertolini F, Battaglia M, Pedrazzoli P et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 1997; 89: 2679-2688.
17. + blood progenitors for anticancer therapy. Exp Hematol 1995; 23: 1463-1471.
18. + progenitors in human bone marrow. J Immunol 1992; 149: 2681-2688.
19. Caux C, Dezutter-Dambuyant C, Shmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258-261.
20. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 1995; 154: 5851-5861.
21. Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157-165.
22. Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation of adults. Proc Natl Acad Sci USA 1992; 89: 4109-4113.
23. + cells. Blood 1994; 84: 2930-2939.
24. + cells using indirect immunomagnetic procedures and a magnetic cell separation system. In: Wunder E, Sovalat H, Henon PR, Serke S (eds). Hematopoietic Stem Cells: The Mulhouse Manual. AlphaMed Press: Dayton, OH, 1994, pp 171-182.
25. + cells. Leukemia 1992; 6: 845-852.
26. + hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting. Cytometry 1993; 14: 384-392.
27. + cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells 1995; 13: 524-532.
28. + selection systems. Stem Cells 1997; 15: 297-304.
29. + blood cells. Br J Haematol 1996; 94: 716-721.
30. + cell separation. Bone Marrow Transplant 1998; 21: 665-671.
31. + cell engraftment, ex vivo expansion, and malignant cell depletion following immunomagnetic selection. J Hematother 1998; 7: 175-183.
32. + cells from human cord blood: comparison of separation techniques and cytokine requirements for optimal growth of clonogenic progenitors. Br J Haematol 1996; 94: 449-454.
33. + cell selection in chronic phase myeloid leukaemia: a comparison of laboratory grade columns. Bone Marrow Transplant 1997; 20: 409-413.
34. Schipper LF, Brand A, Reniers CM et al. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood. Br J Haematol 1998; 101: 425-435.
35. + selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation. Exp Hematol 1995; 23: 1492-1496.
36. + cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays. Cytok Cell Mol Ther 1997; 3: 21-26.
37. Fritsch G, Emminger W, Buchinger P. CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 1991; 19: 1079-1083.
38. + bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques. Bone Marrow Transplant 1998; 21: 933-938.